{"status": "Succeeded", "recognitionResults": [{"page": 1, "clockwiseOrientation": 0.05, "width": 1709, "height": 2288, "unit": "pixel", "lines": [{"boundingBox": [210, 243, 562, 242, 563, 275, 210, 276], "text": "5.2 Brand Protection", "words": [{"boundingBox": [210, 243, 258, 243, 259, 276, 211, 276], "text": "5.2"}, {"boundingBox": [286, 243, 386, 243, 387, 275, 287, 276], "text": "Brand"}, {"boundingBox": [393, 243, 560, 243, 560, 276, 393, 275], "text": "Protection"}]}, {"boundingBox": [206, 318, 1404, 321, 1403, 356, 205, 353], "text": "The TMG family will be protected through a variety of mechanisms depending on", "words": [{"boundingBox": [208, 319, 268, 319, 270, 353, 209, 353], "text": "The"}, {"boundingBox": [277, 319, 344, 320, 345, 354, 278, 353], "text": "TMG"}, {"boundingBox": [355, 320, 444, 321, 446, 354, 356, 354], "text": "family"}, {"boundingBox": [451, 321, 502, 321, 503, 355, 452, 354], "text": "will"}, {"boundingBox": [509, 321, 549, 322, 550, 355, 510, 355], "text": "be"}, {"boundingBox": [555, 322, 696, 322, 697, 355, 557, 355], "text": "protected"}, {"boundingBox": [702, 322, 818, 323, 820, 356, 704, 355], "text": "through"}, {"boundingBox": [827, 323, 847, 323, 849, 356, 829, 356], "text": "a"}, {"boundingBox": [854, 323, 954, 323, 956, 356, 855, 356], "text": "variety"}, {"boundingBox": [961, 323, 990, 323, 991, 356, 962, 356], "text": "of"}, {"boundingBox": [996, 323, 1190, 322, 1192, 355, 998, 356], "text": "mechanisms"}, {"boundingBox": [1197, 322, 1355, 321, 1356, 355, 1198, 355], "text": "depending"}, {"boundingBox": [1361, 321, 1401, 321, 1403, 354, 1363, 355], "text": "on"}]}, {"boundingBox": [200, 358, 1311, 359, 1310, 392, 199, 391], "text": "formulation and region. Overall, the substance patent for TMG has expired.", "words": [{"boundingBox": [206, 359, 374, 359, 374, 392, 206, 391], "text": "formulation"}, {"boundingBox": [383, 359, 440, 359, 439, 392, 383, 392], "text": "and"}, {"boundingBox": [446, 359, 553, 359, 553, 393, 446, 392], "text": "region."}, {"boundingBox": [559, 359, 675, 359, 675, 393, 559, 393], "text": "Overall,"}, {"boundingBox": [681, 359, 732, 359, 732, 393, 681, 393], "text": "the"}, {"boundingBox": [738, 359, 891, 359, 891, 393, 738, 393], "text": "substance"}, {"boundingBox": [898, 359, 994, 359, 994, 393, 898, 393], "text": "patent"}, {"boundingBox": [1000, 359, 1047, 359, 1047, 393, 1001, 393], "text": "for"}, {"boundingBox": [1053, 359, 1120, 359, 1121, 393, 1053, 393], "text": "TMG"}, {"boundingBox": [1131, 359, 1190, 359, 1190, 393, 1131, 393], "text": "has"}, {"boundingBox": [1196, 359, 1309, 359, 1310, 392, 1196, 393], "text": "expired."}]}, {"boundingBox": [240, 397, 1409, 396, 1410, 435, 241, 436], "text": "Premarin/TMG will have three years data exclusivity protection in the US post-", "words": [{"boundingBox": [257, 399, 476, 400, 475, 435, 256, 434], "text": "Premarin/TMG"}, {"boundingBox": [485, 400, 534, 401, 534, 435, 484, 435], "text": "will"}, {"boundingBox": [541, 401, 615, 401, 615, 436, 540, 435], "text": "have"}, {"boundingBox": [622, 401, 701, 401, 701, 436, 622, 436], "text": "three"}, {"boundingBox": [708, 401, 795, 401, 795, 436, 707, 436], "text": "years"}, {"boundingBox": [802, 401, 865, 401, 865, 436, 802, 436], "text": "data"}, {"boundingBox": [872, 401, 1025, 400, 1025, 436, 872, 436], "text": "exclusivity"}, {"boundingBox": [1032, 400, 1182, 399, 1183, 436, 1032, 436], "text": "protection"}, {"boundingBox": [1189, 399, 1218, 399, 1219, 435, 1190, 436], "text": "in"}, {"boundingBox": [1225, 399, 1275, 398, 1276, 435, 1226, 435], "text": "the"}, {"boundingBox": [1281, 398, 1329, 398, 1330, 435, 1282, 435], "text": "US"}, {"boundingBox": [1335, 398, 1407, 397, 1409, 434, 1337, 435], "text": "post-"}]}, {"boundingBox": [262, 441, 397, 438, 398, 469, 263, 473], "text": "approval.", "words": [{"boundingBox": [264, 441, 397, 440, 396, 470, 263, 474], "text": "approval."}]}, {"boundingBox": [244, 476, 1198, 479, 1197, 516, 243, 513], "text": "Wolfe-Plunkett: Expires in 05/2006 and covers cc HT regimens.", "words": [{"boundingBox": [256, 477, 487, 478, 487, 514, 255, 512], "text": "Wolfe-Plunkett:"}, {"boundingBox": [494, 478, 605, 478, 605, 515, 494, 514], "text": "Expires"}, {"boundingBox": [612, 478, 642, 478, 642, 515, 612, 515], "text": "in"}, {"boundingBox": [649, 478, 774, 478, 774, 516, 649, 515], "text": "05/2006"}, {"boundingBox": [781, 478, 836, 478, 836, 516, 781, 516], "text": "and"}, {"boundingBox": [843, 478, 945, 479, 945, 516, 843, 516], "text": "covers"}, {"boundingBox": [952, 479, 986, 479, 987, 516, 952, 516], "text": "cc"}, {"boundingBox": [993, 479, 1039, 479, 1040, 515, 994, 515], "text": "HT"}, {"boundingBox": [1046, 479, 1196, 480, 1197, 515, 1047, 515], "text": "regimens."}]}, {"boundingBox": [255, 516, 1460, 517, 1460, 554, 254, 553], "text": "Data Protection: In Europe, both the Premarin/TMG and 17-E2/TMG will receive", "words": [{"boundingBox": [258, 518, 330, 519, 330, 553, 258, 553], "text": "Data"}, {"boundingBox": [336, 519, 498, 519, 498, 554, 336, 553], "text": "Protection:"}, {"boundingBox": [505, 519, 536, 519, 536, 554, 505, 554], "text": "In"}, {"boundingBox": [543, 519, 662, 519, 662, 554, 543, 554], "text": "Europe,"}, {"boundingBox": [669, 519, 736, 519, 736, 554, 669, 554], "text": "both"}, {"boundingBox": [743, 519, 792, 519, 792, 554, 743, 554], "text": "the"}, {"boundingBox": [799, 519, 1017, 519, 1017, 554, 799, 554], "text": "Premarin/TMG"}, {"boundingBox": [1028, 519, 1087, 519, 1086, 554, 1028, 554], "text": "and"}, {"boundingBox": [1096, 519, 1282, 518, 1282, 554, 1095, 555], "text": "17-E2/TMG", "confidence": "Low"}, {"boundingBox": [1291, 518, 1340, 518, 1340, 554, 1291, 554], "text": "will"}, {"boundingBox": [1347, 518, 1459, 517, 1459, 554, 1347, 554], "text": "receive"}]}, {"boundingBox": [258, 557, 1265, 557, 1264, 595, 257, 594], "text": "data protection for eight to ten years depending on local regulations.", "words": [{"boundingBox": [263, 557, 324, 558, 323, 594, 262, 593], "text": "data"}, {"boundingBox": [331, 558, 480, 558, 479, 595, 330, 594], "text": "protection"}, {"boundingBox": [487, 558, 529, 558, 529, 595, 486, 595], "text": "for"}, {"boundingBox": [536, 558, 611, 558, 610, 595, 536, 595], "text": "eight"}, {"boundingBox": [618, 558, 648, 558, 648, 595, 617, 595], "text": "to"}, {"boundingBox": [655, 558, 704, 558, 704, 596, 655, 595], "text": "ten"}, {"boundingBox": [711, 558, 800, 558, 799, 596, 711, 596], "text": "years"}, {"boundingBox": [807, 558, 958, 558, 958, 595, 806, 596], "text": "depending"}, {"boundingBox": [965, 558, 1002, 558, 1003, 595, 965, 595], "text": "on"}, {"boundingBox": [1009, 558, 1082, 558, 1082, 595, 1010, 595], "text": "local"}, {"boundingBox": [1089, 558, 1264, 558, 1264, 593, 1089, 595], "text": "regulations."}]}, {"boundingBox": [241, 598, 1336, 596, 1337, 635, 242, 636], "text": "Premarin/TMG unitary tablet formulation has patent protection until 2015.", "words": [{"boundingBox": [256, 599, 475, 599, 476, 636, 257, 635], "text": "Premarin/TMG"}, {"boundingBox": [484, 599, 587, 599, 588, 636, 485, 636], "text": "unitary"}, {"boundingBox": [594, 599, 677, 599, 678, 636, 595, 636], "text": "tablet"}, {"boundingBox": [684, 599, 851, 599, 853, 636, 686, 636], "text": "formulation"}, {"boundingBox": [858, 599, 913, 599, 915, 636, 860, 636], "text": "has"}, {"boundingBox": [920, 599, 1015, 598, 1017, 636, 922, 636], "text": "patent"}, {"boundingBox": [1022, 598, 1172, 598, 1174, 635, 1024, 636], "text": "protection"}, {"boundingBox": [1179, 598, 1246, 597, 1248, 634, 1182, 635], "text": "until"}, {"boundingBox": [1253, 597, 1334, 597, 1336, 633, 1255, 634], "text": "2015."}]}, {"boundingBox": [210, 673, 877, 675, 876, 714, 209, 711], "text": "5.3 Market and Competitive Assessment", "words": [{"boundingBox": [210, 673, 261, 674, 263, 711, 212, 711], "text": "5.3", "confidence": "Low"}, {"boundingBox": [285, 674, 398, 675, 399, 712, 287, 711], "text": "Market"}, {"boundingBox": [405, 675, 466, 676, 468, 713, 407, 713], "text": "and"}, {"boundingBox": [473, 676, 666, 677, 668, 713, 475, 713], "text": "Competitive"}, {"boundingBox": [674, 678, 874, 678, 875, 711, 675, 713], "text": "Assessment"}]}, {"boundingBox": [206, 750, 1450, 750, 1449, 787, 205, 786], "text": "In July 2002, the NIH announced that the continuous combined arm of the Women's", "words": [{"boundingBox": [206, 750, 238, 750, 239, 788, 207, 788], "text": "In"}, {"boundingBox": [246, 750, 305, 751, 306, 788, 247, 788], "text": "July"}, {"boundingBox": [313, 751, 397, 751, 398, 788, 314, 788], "text": "2002,"}, {"boundingBox": [405, 751, 452, 752, 453, 788, 406, 788], "text": "the"}, {"boundingBox": [460, 752, 519, 752, 520, 788, 460, 788], "text": "NIH"}, {"boundingBox": [529, 752, 696, 753, 696, 788, 530, 788], "text": "announced"}, {"boundingBox": [703, 753, 761, 753, 761, 788, 704, 788], "text": "that"}, {"boundingBox": [768, 753, 815, 753, 816, 788, 769, 788], "text": "the"}, {"boundingBox": [823, 753, 987, 753, 987, 787, 823, 788], "text": "continuous"}, {"boundingBox": [995, 753, 1141, 753, 1141, 787, 995, 787], "text": "combined"}, {"boundingBox": [1149, 753, 1201, 752, 1201, 787, 1149, 787], "text": "arm"}, {"boundingBox": [1216, 752, 1246, 752, 1246, 787, 1216, 787], "text": "of"}, {"boundingBox": [1253, 752, 1301, 752, 1300, 787, 1253, 787], "text": "the"}, {"boundingBox": [1308, 752, 1450, 751, 1450, 787, 1308, 787], "text": "Women's"}]}, {"boundingBox": [209, 790, 1417, 790, 1416, 827, 208, 826], "text": "Health Initiative Study was halted prematurely due to findings of increased risk for", "words": [{"boundingBox": [209, 790, 305, 790, 305, 826, 209, 825], "text": "Health"}, {"boundingBox": [312, 790, 439, 791, 439, 827, 312, 826], "text": "Initiative"}, {"boundingBox": [446, 791, 530, 792, 531, 827, 446, 827], "text": "Study"}, {"boundingBox": [537, 792, 601, 792, 601, 828, 538, 827], "text": "was"}, {"boundingBox": [608, 792, 702, 793, 702, 828, 608, 828], "text": "halted"}, {"boundingBox": [709, 793, 889, 793, 890, 828, 709, 828], "text": "prematurely"}, {"boundingBox": [896, 793, 950, 793, 951, 828, 897, 828], "text": "due"}, {"boundingBox": [957, 793, 988, 793, 988, 828, 958, 828], "text": "to"}, {"boundingBox": [995, 793, 1115, 793, 1115, 827, 995, 828], "text": "findings"}, {"boundingBox": [1122, 793, 1150, 793, 1150, 827, 1122, 827], "text": "of"}, {"boundingBox": [1157, 793, 1305, 792, 1305, 826, 1157, 827], "text": "increased"}, {"boundingBox": [1312, 792, 1366, 792, 1366, 825, 1312, 826], "text": "risk"}, {"boundingBox": [1373, 792, 1417, 791, 1418, 825, 1373, 825], "text": "for"}]}, {"boundingBox": [206, 831, 1472, 828, 1473, 864, 207, 867], "text": "cardiovascular disease and breast cancer. Significant global media attention followed.", "words": [{"boundingBox": [209, 832, 429, 833, 429, 865, 209, 864], "text": "cardiovascular"}, {"boundingBox": [435, 833, 549, 834, 550, 866, 436, 865], "text": "disease"}, {"boundingBox": [557, 834, 614, 834, 615, 866, 558, 866], "text": "and"}, {"boundingBox": [620, 834, 717, 834, 719, 866, 621, 866], "text": "breast"}, {"boundingBox": [724, 834, 838, 834, 839, 866, 725, 866], "text": "cancer."}, {"boundingBox": [844, 834, 998, 833, 1000, 866, 845, 866], "text": "Significant"}, {"boundingBox": [1004, 833, 1095, 832, 1097, 865, 1006, 866], "text": "global"}, {"boundingBox": [1101, 832, 1198, 832, 1200, 865, 1103, 865], "text": "media"}, {"boundingBox": [1204, 832, 1333, 830, 1336, 864, 1207, 865], "text": "attention"}, {"boundingBox": [1341, 830, 1470, 829, 1473, 863, 1344, 864], "text": "followed."}]}, {"boundingBox": [207, 866, 1472, 866, 1472, 902, 208, 903], "text": "The impact on prescriptions trends has varied from region to region, however both ET", "words": [{"boundingBox": [213, 867, 266, 868, 263, 904, 210, 904], "text": "The"}, {"boundingBox": [273, 868, 376, 868, 374, 904, 270, 904], "text": "impact"}, {"boundingBox": [384, 868, 422, 869, 420, 904, 381, 904], "text": "on"}, {"boundingBox": [429, 869, 619, 869, 618, 904, 427, 904], "text": "prescriptions"}, {"boundingBox": [627, 869, 721, 869, 719, 904, 625, 904], "text": "trends"}, {"boundingBox": [728, 869, 786, 869, 784, 904, 726, 904], "text": "has"}, {"boundingBox": [793, 869, 884, 869, 883, 904, 791, 904], "text": "varied"}, {"boundingBox": [891, 869, 954, 869, 953, 904, 890, 904], "text": "from"}, {"boundingBox": [966, 869, 1062, 869, 1061, 904, 965, 904], "text": "region"}, {"boundingBox": [1070, 869, 1098, 869, 1097, 904, 1068, 904], "text": "to"}, {"boundingBox": [1106, 869, 1209, 868, 1208, 904, 1105, 904], "text": "region,"}, {"boundingBox": [1216, 868, 1346, 867, 1346, 903, 1216, 904], "text": "however"}, {"boundingBox": [1354, 867, 1421, 867, 1421, 903, 1353, 903], "text": "both"}, {"boundingBox": [1428, 867, 1472, 866, 1471, 903, 1428, 903], "text": "ET"}]}, {"boundingBox": [207, 905, 1432, 905, 1432, 943, 208, 944], "text": "and HT markets are down approximately 15% and 35% respectively. Premarin and", "words": [{"boundingBox": [208, 906, 263, 906, 263, 942, 208, 941], "text": "and"}, {"boundingBox": [270, 906, 317, 907, 316, 942, 270, 942], "text": "HT"}, {"boundingBox": [323, 907, 448, 907, 448, 944, 323, 943], "text": "markets"}, {"boundingBox": [455, 907, 506, 907, 505, 944, 455, 944], "text": "are"}, {"boundingBox": [517, 907, 593, 907, 593, 944, 517, 944], "text": "down"}, {"boundingBox": [600, 907, 812, 907, 812, 945, 600, 944], "text": "approximately"}, {"boundingBox": [819, 907, 886, 907, 886, 945, 819, 945], "text": "15%"}, {"boundingBox": [893, 907, 951, 907, 950, 945, 893, 945], "text": "and"}, {"boundingBox": [958, 907, 1025, 907, 1024, 945, 957, 945], "text": "35%"}, {"boundingBox": [1032, 907, 1221, 906, 1220, 944, 1031, 945], "text": "respectively."}, {"boundingBox": [1228, 906, 1368, 906, 1368, 943, 1227, 944], "text": "Premarin"}, {"boundingBox": [1375, 906, 1431, 905, 1430, 942, 1375, 942], "text": "and"}]}, {"boundingBox": [209, 944, 1444, 945, 1443, 981, 208, 980], "text": "Prempro have both declined while Activella and FemHRT have remained stable. No", "words": [{"boundingBox": [209, 945, 335, 945, 335, 980, 209, 980], "text": "Prempro"}, {"boundingBox": [342, 945, 418, 945, 417, 981, 342, 980], "text": "have"}, {"boundingBox": [425, 945, 493, 945, 493, 981, 424, 981], "text": "both"}, {"boundingBox": [505, 945, 626, 945, 626, 981, 505, 981], "text": "declined"}, {"boundingBox": [633, 945, 711, 946, 711, 981, 633, 981], "text": "while"}, {"boundingBox": [718, 946, 846, 946, 846, 982, 718, 981], "text": "Activella"}, {"boundingBox": [853, 946, 911, 946, 911, 982, 853, 982], "text": "and"}, {"boundingBox": [918, 946, 1053, 946, 1053, 981, 918, 982], "text": "FemHRT"}, {"boundingBox": [1060, 946, 1135, 946, 1136, 981, 1060, 981], "text": "have"}, {"boundingBox": [1142, 946, 1287, 945, 1287, 981, 1142, 981], "text": "remained"}, {"boundingBox": [1293, 945, 1392, 945, 1392, 981, 1294, 981], "text": "stable."}, {"boundingBox": [1399, 945, 1442, 945, 1443, 980, 1399, 981], "text": "No"}]}, {"boundingBox": [203, 982, 1381, 983, 1380, 1018, 203, 1018], "text": "single combination HT product has increased following the WHI announcement,", "words": [{"boundingBox": [209, 985, 296, 984, 295, 1018, 207, 1018], "text": "single"}, {"boundingBox": [303, 984, 486, 983, 484, 1018, 302, 1018], "text": "combination"}, {"boundingBox": [492, 983, 541, 983, 539, 1018, 491, 1018], "text": "HT"}, {"boundingBox": [547, 983, 662, 983, 660, 1018, 546, 1018], "text": "product"}, {"boundingBox": [668, 983, 723, 983, 721, 1018, 666, 1018], "text": "has"}, {"boundingBox": [730, 983, 877, 983, 875, 1018, 728, 1018], "text": "increased"}, {"boundingBox": [884, 983, 1016, 983, 1013, 1018, 881, 1018], "text": "following"}, {"boundingBox": [1022, 983, 1073, 983, 1070, 1018, 1020, 1018], "text": "the"}, {"boundingBox": [1079, 983, 1150, 984, 1147, 1018, 1077, 1018], "text": "WHI"}, {"boundingBox": [1156, 984, 1381, 986, 1378, 1019, 1154, 1018], "text": "announcement,"}]}, {"boundingBox": [200, 1020, 1424, 1021, 1424, 1059, 199, 1058], "text": "however, Livial (tibolone) is still experiencing growth in all regions where launched.", "words": [{"boundingBox": [205, 1021, 343, 1022, 343, 1057, 204, 1056], "text": "however,"}, {"boundingBox": [350, 1022, 430, 1022, 429, 1058, 350, 1057], "text": "Livial"}, {"boundingBox": [436, 1022, 577, 1022, 576, 1059, 436, 1058], "text": "(tibolone)"}, {"boundingBox": [584, 1022, 613, 1022, 613, 1059, 583, 1059], "text": "is"}, {"boundingBox": [620, 1022, 670, 1022, 669, 1059, 620, 1059], "text": "still"}, {"boundingBox": [677, 1022, 868, 1022, 867, 1060, 676, 1059], "text": "experiencing"}, {"boundingBox": [874, 1022, 974, 1022, 973, 1059, 874, 1060], "text": "growth"}, {"boundingBox": [981, 1022, 1013, 1022, 1012, 1059, 980, 1059], "text": "in"}, {"boundingBox": [1020, 1022, 1054, 1022, 1053, 1059, 1019, 1059], "text": "all"}, {"boundingBox": [1061, 1022, 1174, 1022, 1173, 1059, 1060, 1059], "text": "regions"}, {"boundingBox": [1181, 1022, 1274, 1021, 1273, 1058, 1180, 1059], "text": "where"}, {"boundingBox": [1281, 1021, 1424, 1021, 1423, 1057, 1280, 1058], "text": "launched."}]}, {"boundingBox": [206, 1098, 1485, 1097, 1485, 1133, 207, 1134], "text": "Aside from the immediate impact on the ET/HT market, the WHI findings have resulted", "words": [{"boundingBox": [208, 1098, 293, 1099, 292, 1133, 207, 1132], "text": "Aside"}, {"boundingBox": [300, 1099, 360, 1099, 358, 1133, 298, 1133], "text": "from"}, {"boundingBox": [375, 1099, 425, 1099, 423, 1134, 374, 1133], "text": "the"}, {"boundingBox": [431, 1099, 587, 1100, 586, 1134, 430, 1134], "text": "immediate"}, {"boundingBox": [594, 1100, 697, 1100, 695, 1135, 593, 1134], "text": "impact"}, {"boundingBox": [703, 1100, 741, 1100, 740, 1135, 702, 1135], "text": "on"}, {"boundingBox": [748, 1100, 799, 1100, 798, 1135, 747, 1135], "text": "the"}, {"boundingBox": [806, 1100, 902, 1100, 901, 1135, 805, 1135], "text": "ET/HT"}, {"boundingBox": [908, 1100, 1024, 1100, 1023, 1135, 907, 1135], "text": "market,"}, {"boundingBox": [1031, 1100, 1080, 1100, 1079, 1135, 1030, 1135], "text": "the"}, {"boundingBox": [1087, 1100, 1154, 1100, 1153, 1134, 1086, 1135], "text": "WHI"}, {"boundingBox": [1160, 1100, 1279, 1099, 1278, 1134, 1159, 1134], "text": "findings"}, {"boundingBox": [1285, 1099, 1359, 1099, 1358, 1134, 1284, 1134], "text": "have"}, {"boundingBox": [1366, 1099, 1484, 1098, 1483, 1133, 1365, 1134], "text": "resulted"}]}, {"boundingBox": [209, 1134, 1475, 1138, 1474, 1175, 208, 1171], "text": "in the redefinition of attitudes and usage regarding hormone therapy in many markets.", "words": [{"boundingBox": [210, 1135, 236, 1136, 234, 1171, 209, 1171], "text": "in"}, {"boundingBox": [243, 1136, 291, 1136, 289, 1171, 241, 1171], "text": "the"}, {"boundingBox": [298, 1136, 464, 1137, 462, 1172, 296, 1171], "text": "redefinition"}, {"boundingBox": [471, 1137, 503, 1137, 501, 1172, 469, 1172], "text": "of"}, {"boundingBox": [510, 1137, 639, 1138, 637, 1173, 508, 1172], "text": "attitudes"}, {"boundingBox": [646, 1138, 701, 1138, 699, 1173, 644, 1173], "text": "and"}, {"boundingBox": [708, 1138, 800, 1139, 798, 1173, 706, 1173], "text": "usage"}, {"boundingBox": [807, 1139, 950, 1139, 948, 1174, 805, 1173], "text": "regarding"}, {"boundingBox": [957, 1139, 1093, 1139, 1091, 1174, 955, 1174], "text": "hormone"}, {"boundingBox": [1100, 1139, 1212, 1139, 1211, 1174, 1098, 1174], "text": "therapy"}, {"boundingBox": [1219, 1139, 1249, 1139, 1248, 1174, 1218, 1174], "text": "in"}, {"boundingBox": [1256, 1139, 1341, 1139, 1340, 1174, 1254, 1174], "text": "many"}, {"boundingBox": [1348, 1139, 1475, 1139, 1473, 1174, 1347, 1174], "text": "markets."}]}, {"boundingBox": [207, 1176, 1446, 1177, 1446, 1212, 206, 1211], "text": "The majority of physicians state they will only prescribe HT for symptomatic patients", "words": [{"boundingBox": [210, 1177, 266, 1177, 265, 1210, 209, 1210], "text": "The"}, {"boundingBox": [272, 1177, 393, 1177, 392, 1211, 272, 1210], "text": "majority"}, {"boundingBox": [399, 1177, 429, 1177, 429, 1211, 399, 1211], "text": "of"}, {"boundingBox": [436, 1177, 597, 1178, 596, 1212, 435, 1211], "text": "physicians"}, {"boundingBox": [604, 1178, 677, 1178, 676, 1212, 603, 1212], "text": "state"}, {"boundingBox": [683, 1178, 750, 1178, 749, 1212, 682, 1212], "text": "they"}, {"boundingBox": [756, 1178, 806, 1178, 805, 1212, 755, 1212], "text": "will"}, {"boundingBox": [812, 1178, 874, 1178, 874, 1212, 811, 1212], "text": "only"}, {"boundingBox": [881, 1178, 1023, 1178, 1022, 1212, 880, 1212], "text": "prescribe"}, {"boundingBox": [1029, 1178, 1074, 1177, 1073, 1212, 1028, 1212], "text": "HT"}, {"boundingBox": [1081, 1177, 1126, 1177, 1125, 1212, 1080, 1212], "text": "for"}, {"boundingBox": [1133, 1177, 1322, 1177, 1321, 1211, 1132, 1212], "text": "symptomatic"}, {"boundingBox": [1328, 1177, 1446, 1177, 1445, 1211, 1327, 1211], "text": "patients"}]}, {"boundingBox": [207, 1212, 1504, 1213, 1503, 1250, 206, 1249], "text": "and for a limited period of time, usually no more than 5 years. The risk /benefit equation", "words": [{"boundingBox": [209, 1214, 264, 1215, 266, 1248, 211, 1248], "text": "and"}, {"boundingBox": [271, 1215, 313, 1215, 315, 1248, 273, 1248], "text": "for"}, {"boundingBox": [320, 1216, 340, 1216, 341, 1248, 321, 1248], "text": "a"}, {"boundingBox": [346, 1216, 445, 1217, 447, 1249, 348, 1248], "text": "limited"}, {"boundingBox": [452, 1217, 549, 1218, 551, 1249, 454, 1249], "text": "period"}, {"boundingBox": [556, 1218, 587, 1218, 589, 1249, 558, 1249], "text": "of"}, {"boundingBox": [593, 1218, 666, 1218, 668, 1249, 595, 1249], "text": "time,"}, {"boundingBox": [673, 1218, 779, 1218, 781, 1250, 675, 1249], "text": "usually"}, {"boundingBox": [785, 1218, 825, 1218, 827, 1250, 787, 1250], "text": "no"}, {"boundingBox": [832, 1218, 911, 1218, 913, 1250, 834, 1250], "text": "more"}, {"boundingBox": [918, 1218, 986, 1218, 988, 1250, 920, 1250], "text": "than"}, {"boundingBox": [993, 1218, 1013, 1218, 1015, 1250, 995, 1250], "text": "5"}, {"boundingBox": [1019, 1218, 1118, 1217, 1121, 1250, 1021, 1250], "text": "years."}, {"boundingBox": [1125, 1217, 1180, 1217, 1183, 1250, 1128, 1250], "text": "The"}, {"boundingBox": [1187, 1217, 1240, 1216, 1242, 1250, 1189, 1250], "text": "risk"}, {"boundingBox": [1246, 1216, 1361, 1215, 1364, 1250, 1249, 1250], "text": "/benefit"}, {"boundingBox": [1368, 1215, 1498, 1213, 1501, 1250, 1370, 1250], "text": "equation"}]}, {"boundingBox": [204, 1251, 1506, 1253, 1505, 1291, 203, 1288], "text": "no longer supports long-term use of HT. For the protection of bone alone in menopausal", "words": [{"boundingBox": [206, 1255, 246, 1255, 245, 1288, 206, 1289], "text": "no"}, {"boundingBox": [252, 1255, 349, 1254, 348, 1288, 252, 1288], "text": "longer"}, {"boundingBox": [355, 1254, 485, 1254, 484, 1287, 355, 1288], "text": "supports"}, {"boundingBox": [491, 1254, 628, 1253, 627, 1287, 491, 1287], "text": "long-term"}, {"boundingBox": [643, 1253, 700, 1253, 699, 1287, 642, 1287], "text": "use"}, {"boundingBox": [707, 1253, 737, 1253, 737, 1287, 706, 1287], "text": "of"}, {"boundingBox": [744, 1253, 799, 1253, 798, 1287, 743, 1287], "text": "HT."}, {"boundingBox": [805, 1253, 858, 1253, 857, 1287, 805, 1287], "text": "For"}, {"boundingBox": [865, 1253, 913, 1253, 912, 1287, 864, 1287], "text": "the"}, {"boundingBox": [919, 1253, 1071, 1253, 1070, 1288, 919, 1287], "text": "protection"}, {"boundingBox": [1077, 1253, 1106, 1254, 1105, 1288, 1077, 1288], "text": "of"}, {"boundingBox": [1112, 1254, 1191, 1254, 1191, 1288, 1112, 1288], "text": "bone"}, {"boundingBox": [1198, 1254, 1281, 1254, 1281, 1289, 1197, 1288], "text": "alone"}, {"boundingBox": [1288, 1254, 1317, 1255, 1316, 1289, 1287, 1289], "text": "in"}, {"boundingBox": [1323, 1255, 1505, 1256, 1504, 1291, 1322, 1289], "text": "menopausal"}]}, {"boundingBox": [204, 1294, 1373, 1293, 1373, 1327, 205, 1328], "text": "women, physicians are more likely to seek alternative treatment therapies. It is", "words": [{"boundingBox": [205, 1296, 325, 1295, 325, 1327, 205, 1327], "text": "women,"}, {"boundingBox": [331, 1295, 491, 1294, 492, 1328, 331, 1327], "text": "physicians"}, {"boundingBox": [498, 1294, 548, 1294, 549, 1328, 498, 1328], "text": "are"}, {"boundingBox": [555, 1294, 634, 1294, 634, 1328, 555, 1328], "text": "more"}, {"boundingBox": [640, 1294, 717, 1294, 718, 1328, 640, 1328], "text": "likely"}, {"boundingBox": [723, 1294, 754, 1294, 754, 1328, 724, 1328], "text": "to"}, {"boundingBox": [762, 1294, 835, 1294, 836, 1328, 762, 1328], "text": "seek"}, {"boundingBox": [841, 1294, 996, 1294, 996, 1328, 842, 1328], "text": "alternative"}, {"boundingBox": [1002, 1294, 1149, 1294, 1149, 1328, 1002, 1328], "text": "treatment"}, {"boundingBox": [1155, 1294, 1314, 1294, 1313, 1328, 1155, 1328], "text": "therapies."}, {"boundingBox": [1320, 1294, 1340, 1294, 1340, 1328, 1320, 1328], "text": "It"}, {"boundingBox": [1346, 1294, 1373, 1294, 1372, 1328, 1346, 1328], "text": "is"}]}, {"boundingBox": [208, 1330, 1446, 1332, 1446, 1368, 207, 1366], "text": "important to note in many of the markets outside of the U.S., treatment duration has", "words": [{"boundingBox": [208, 1333, 347, 1333, 348, 1365, 209, 1364], "text": "important"}, {"boundingBox": [353, 1333, 385, 1333, 386, 1365, 355, 1365], "text": "to"}, {"boundingBox": [391, 1333, 459, 1333, 460, 1365, 392, 1365], "text": "note"}, {"boundingBox": [466, 1333, 495, 1333, 496, 1365, 467, 1365], "text": "in"}, {"boundingBox": [501, 1333, 586, 1333, 587, 1366, 502, 1366], "text": "many"}, {"boundingBox": [592, 1333, 624, 1333, 624, 1366, 593, 1366], "text": "of"}, {"boundingBox": [630, 1333, 678, 1333, 678, 1366, 630, 1366], "text": "the"}, {"boundingBox": [684, 1333, 806, 1333, 807, 1366, 684, 1366], "text": "markets"}, {"boundingBox": [813, 1333, 923, 1333, 923, 1367, 813, 1367], "text": "outside"}, {"boundingBox": [931, 1333, 960, 1333, 960, 1367, 931, 1367], "text": "of"}, {"boundingBox": [966, 1333, 1016, 1333, 1016, 1367, 967, 1367], "text": "the"}, {"boundingBox": [1025, 1333, 1099, 1333, 1099, 1367, 1025, 1367], "text": "U.S.,"}, {"boundingBox": [1106, 1333, 1253, 1332, 1253, 1368, 1106, 1367], "text": "treatment"}, {"boundingBox": [1260, 1332, 1380, 1332, 1379, 1368, 1259, 1368], "text": "duration"}, {"boundingBox": [1388, 1332, 1447, 1332, 1446, 1368, 1388, 1368], "text": "has"}]}, {"boundingBox": [200, 1367, 1106, 1368, 1105, 1404, 200, 1404], "text": "historically been short-term focused on symptomatic patients.", "words": [{"boundingBox": [208, 1368, 363, 1368, 361, 1404, 205, 1404], "text": "historically"}, {"boundingBox": [370, 1368, 449, 1369, 448, 1404, 368, 1404], "text": "been"}, {"boundingBox": [457, 1369, 605, 1369, 604, 1404, 455, 1404], "text": "short-term"}, {"boundingBox": [617, 1369, 737, 1370, 736, 1404, 616, 1404], "text": "focused"}, {"boundingBox": [744, 1370, 785, 1370, 784, 1404, 743, 1404], "text": "on"}, {"boundingBox": [792, 1370, 979, 1370, 979, 1404, 791, 1404], "text": "symptomatic"}, {"boundingBox": [986, 1370, 1105, 1370, 1106, 1404, 986, 1404], "text": "patients."}]}, {"boundingBox": [206, 1444, 1495, 1445, 1494, 1482, 205, 1481], "text": "Despite the redefinition of HT use, positive demographic trends globally will continue to", "words": [{"boundingBox": [206, 1445, 322, 1446, 323, 1480, 207, 1479], "text": "Despite"}, {"boundingBox": [329, 1446, 375, 1446, 376, 1481, 329, 1480], "text": "the"}, {"boundingBox": [382, 1446, 552, 1447, 552, 1482, 383, 1481], "text": "redefinition"}, {"boundingBox": [558, 1447, 587, 1447, 588, 1482, 559, 1482], "text": "of"}, {"boundingBox": [594, 1447, 641, 1447, 642, 1482, 595, 1482], "text": "HT"}, {"boundingBox": [648, 1447, 712, 1448, 713, 1482, 648, 1482], "text": "use,"}, {"boundingBox": [719, 1448, 837, 1448, 838, 1482, 720, 1482], "text": "positive"}, {"boundingBox": [846, 1448, 1036, 1447, 1036, 1482, 847, 1482], "text": "demographic"}, {"boundingBox": [1043, 1447, 1141, 1447, 1141, 1482, 1043, 1482], "text": "trends"}, {"boundingBox": [1147, 1447, 1261, 1447, 1262, 1482, 1148, 1482], "text": "globally"}, {"boundingBox": [1268, 1447, 1319, 1446, 1320, 1482, 1268, 1482], "text": "will"}, {"boundingBox": [1326, 1446, 1453, 1446, 1453, 1481, 1326, 1482], "text": "continue"}, {"boundingBox": [1460, 1446, 1493, 1445, 1493, 1481, 1460, 1481], "text": "to"}]}, {"boundingBox": [207, 1483, 1452, 1484, 1452, 1519, 206, 1518], "text": "cause women to seek therapy to alleviate symptoms and maintain quality of life. The", "words": [{"boundingBox": [207, 1485, 297, 1485, 298, 1518, 208, 1517], "text": "cause"}, {"boundingBox": [303, 1485, 413, 1485, 414, 1518, 304, 1518], "text": "women"}, {"boundingBox": [422, 1485, 453, 1485, 453, 1518, 422, 1518], "text": "to"}, {"boundingBox": [459, 1485, 532, 1485, 532, 1519, 460, 1518], "text": "seek"}, {"boundingBox": [538, 1485, 652, 1485, 653, 1519, 539, 1519], "text": "therapy"}, {"boundingBox": [659, 1485, 690, 1485, 690, 1519, 659, 1519], "text": "to"}, {"boundingBox": [696, 1485, 821, 1485, 821, 1519, 697, 1519], "text": "alleviate"}, {"boundingBox": [829, 1485, 983, 1484, 983, 1520, 830, 1519], "text": "symptoms"}, {"boundingBox": [989, 1484, 1045, 1484, 1046, 1520, 990, 1520], "text": "and"}, {"boundingBox": [1052, 1484, 1183, 1484, 1183, 1520, 1052, 1520], "text": "maintain"}, {"boundingBox": [1191, 1484, 1291, 1484, 1291, 1520, 1191, 1520], "text": "quality"}, {"boundingBox": [1297, 1484, 1326, 1484, 1326, 1520, 1297, 1520], "text": "of"}, {"boundingBox": [1332, 1484, 1391, 1484, 1391, 1520, 1332, 1520], "text": "life."}, {"boundingBox": [1397, 1484, 1451, 1484, 1451, 1520, 1397, 1520], "text": "The"}]}, {"boundingBox": [201, 1523, 1497, 1522, 1498, 1558, 202, 1559], "text": "caveat now being that the symptoms must be moderate to severe in order for women to", "words": [{"boundingBox": [206, 1524, 307, 1524, 307, 1559, 207, 1558], "text": "caveat"}, {"boundingBox": [313, 1524, 371, 1524, 372, 1559, 314, 1559], "text": "now"}, {"boundingBox": [382, 1524, 467, 1524, 468, 1559, 383, 1559], "text": "being"}, {"boundingBox": [474, 1524, 534, 1524, 535, 1559, 474, 1559], "text": "that"}, {"boundingBox": [541, 1524, 592, 1524, 593, 1559, 541, 1559], "text": "the"}, {"boundingBox": [598, 1524, 750, 1523, 751, 1560, 599, 1559], "text": "symptoms"}, {"boundingBox": [756, 1523, 830, 1523, 831, 1560, 757, 1560], "text": "must"}, {"boundingBox": [837, 1523, 877, 1523, 878, 1560, 837, 1560], "text": "be"}, {"boundingBox": [883, 1523, 1028, 1523, 1029, 1560, 884, 1560], "text": "moderate"}, {"boundingBox": [1035, 1523, 1066, 1523, 1067, 1559, 1036, 1559], "text": "to"}, {"boundingBox": [1073, 1523, 1173, 1523, 1174, 1559, 1074, 1559], "text": "severe"}, {"boundingBox": [1180, 1523, 1211, 1523, 1212, 1559, 1180, 1559], "text": "in"}, {"boundingBox": [1217, 1523, 1298, 1523, 1299, 1559, 1218, 1559], "text": "order"}, {"boundingBox": [1304, 1523, 1344, 1523, 1345, 1559, 1305, 1559], "text": "for"}, {"boundingBox": [1351, 1523, 1462, 1523, 1463, 1558, 1352, 1559], "text": "women"}, {"boundingBox": [1469, 1523, 1496, 1523, 1497, 1558, 1470, 1558], "text": "to"}]}, {"boundingBox": [204, 1561, 1502, 1563, 1501, 1599, 203, 1598], "text": "seek treatment coupled with any emerging ET/HT guidance and label recommendations", "words": [{"boundingBox": [208, 1563, 280, 1563, 280, 1594, 208, 1593], "text": "seek"}, {"boundingBox": [286, 1563, 431, 1563, 431, 1596, 286, 1594], "text": "treatment"}, {"boundingBox": [437, 1563, 555, 1563, 555, 1598, 437, 1596], "text": "coupled"}, {"boundingBox": [563, 1563, 623, 1563, 623, 1598, 563, 1598], "text": "with"}, {"boundingBox": [633, 1563, 689, 1563, 689, 1598, 633, 1598], "text": "any"}, {"boundingBox": [695, 1563, 834, 1563, 834, 1599, 695, 1599], "text": "emerging"}, {"boundingBox": [842, 1563, 941, 1563, 941, 1599, 842, 1599], "text": "ET/HT"}, {"boundingBox": [947, 1563, 1084, 1563, 1084, 1599, 947, 1599], "text": "guidance"}, {"boundingBox": [1094, 1563, 1150, 1563, 1150, 1598, 1094, 1599], "text": "and"}, {"boundingBox": [1156, 1563, 1232, 1563, 1231, 1598, 1156, 1598], "text": "label"}, {"boundingBox": [1238, 1563, 1501, 1564, 1501, 1595, 1237, 1598], "text": "recommendations"}]}, {"boundingBox": [200, 1599, 1492, 1600, 1491, 1637, 199, 1636], "text": "from the regulatory authorities that may further change the current treatment paradigm.", "words": [{"boundingBox": [205, 1600, 267, 1600, 268, 1637, 205, 1636], "text": "from"}, {"boundingBox": [282, 1600, 330, 1600, 330, 1637, 282, 1637], "text": "the"}, {"boundingBox": [337, 1600, 489, 1600, 489, 1637, 337, 1637], "text": "regulatory"}, {"boundingBox": [496, 1600, 651, 1601, 651, 1637, 497, 1637], "text": "authorities"}, {"boundingBox": [658, 1601, 716, 1601, 716, 1638, 658, 1637], "text": "that"}, {"boundingBox": [723, 1601, 788, 1601, 788, 1638, 723, 1638], "text": "may"}, {"boundingBox": [795, 1601, 894, 1601, 894, 1638, 795, 1638], "text": "further"}, {"boundingBox": [901, 1601, 1012, 1601, 1012, 1638, 901, 1638], "text": "change"}, {"boundingBox": [1019, 1601, 1070, 1601, 1070, 1638, 1020, 1638], "text": "the"}, {"boundingBox": [1077, 1601, 1183, 1601, 1183, 1638, 1077, 1638], "text": "current"}, {"boundingBox": [1191, 1601, 1333, 1601, 1333, 1637, 1191, 1638], "text": "treatment"}, {"boundingBox": [1340, 1601, 1492, 1601, 1492, 1637, 1340, 1637], "text": "paradigm."}]}, {"boundingBox": [206, 1671, 408, 1678, 406, 1715, 204, 1708], "text": "5.4 Pricing", "words": [{"boundingBox": [208, 1672, 259, 1674, 260, 1711, 210, 1708], "text": "5.4"}, {"boundingBox": [285, 1675, 407, 1678, 408, 1714, 286, 1712], "text": "Pricing"}]}, {"boundingBox": [206, 1750, 1503, 1753, 1503, 1793, 205, 1790], "text": "The proposed pricing strategy for Premarin/TMG in the US is parity to existing Prempro", "words": [{"boundingBox": [208, 1754, 266, 1754, 266, 1789, 208, 1789], "text": "The"}, {"boundingBox": [273, 1754, 414, 1753, 414, 1789, 273, 1789], "text": "proposed"}, {"boundingBox": [421, 1753, 525, 1753, 525, 1789, 421, 1789], "text": "pricing"}, {"boundingBox": [532, 1753, 650, 1752, 650, 1789, 532, 1789], "text": "strategy"}, {"boundingBox": [657, 1752, 698, 1752, 698, 1790, 657, 1789], "text": "for"}, {"boundingBox": [705, 1752, 922, 1752, 923, 1790, 705, 1790], "text": "Premarin/TMG"}, {"boundingBox": [932, 1752, 962, 1753, 962, 1790, 932, 1790], "text": "in"}, {"boundingBox": [969, 1753, 1017, 1753, 1017, 1791, 969, 1790], "text": "the"}, {"boundingBox": [1024, 1753, 1073, 1753, 1073, 1791, 1024, 1791], "text": "US"}, {"boundingBox": [1079, 1753, 1105, 1753, 1105, 1791, 1080, 1791], "text": "is"}, {"boundingBox": [1112, 1753, 1197, 1753, 1198, 1792, 1112, 1791], "text": "parity"}, {"boundingBox": [1204, 1753, 1237, 1754, 1237, 1792, 1205, 1792], "text": "to"}, {"boundingBox": [1243, 1754, 1357, 1754, 1357, 1793, 1244, 1792], "text": "existing"}, {"boundingBox": [1364, 1754, 1498, 1755, 1498, 1794, 1364, 1793], "text": "Prempro"}]}, {"boundingBox": [204, 1791, 1523, 1792, 1522, 1829, 203, 1827], "text": "formulations. This strategy will help assure reimbursement and facilitate broad formulary", "words": [{"boundingBox": [207, 1791, 403, 1793, 403, 1828, 208, 1829], "text": "formulations."}, {"boundingBox": [410, 1793, 472, 1793, 473, 1828, 411, 1828], "text": "This"}, {"boundingBox": [480, 1793, 599, 1794, 599, 1828, 480, 1828], "text": "strategy"}, {"boundingBox": [606, 1794, 653, 1794, 653, 1827, 606, 1827], "text": "will"}, {"boundingBox": [661, 1794, 728, 1794, 727, 1827, 661, 1827], "text": "help"}, {"boundingBox": [735, 1794, 834, 1795, 834, 1827, 735, 1827], "text": "assure"}, {"boundingBox": [842, 1795, 1070, 1795, 1069, 1828, 841, 1827], "text": "reimbursement"}, {"boundingBox": [1077, 1795, 1135, 1795, 1133, 1828, 1076, 1828], "text": "and"}, {"boundingBox": [1142, 1795, 1266, 1794, 1264, 1828, 1141, 1828], "text": "facilitate"}, {"boundingBox": [1273, 1794, 1360, 1794, 1358, 1829, 1272, 1828], "text": "broad"}, {"boundingBox": [1368, 1794, 1517, 1793, 1514, 1829, 1366, 1829], "text": "formulary"}]}, {"boundingBox": [204, 1829, 475, 1833, 474, 1866, 203, 1862], "text": "access at launch.", "words": [{"boundingBox": [207, 1833, 312, 1834, 314, 1864, 209, 1861], "text": "access"}, {"boundingBox": [320, 1834, 351, 1834, 353, 1865, 321, 1864], "text": "at"}, {"boundingBox": [357, 1834, 473, 1833, 474, 1867, 358, 1865], "text": "launch."}]}, {"boundingBox": [205, 1904, 1502, 1909, 1502, 1945, 204, 1941], "text": "Because the HT market is expected to continue to change over the next year, managed", "words": [{"boundingBox": [207, 1905, 340, 1906, 339, 1942, 207, 1941], "text": "Because"}, {"boundingBox": [347, 1906, 394, 1906, 394, 1942, 346, 1942], "text": "the"}, {"boundingBox": [401, 1906, 446, 1906, 446, 1942, 401, 1942], "text": "HT"}, {"boundingBox": [453, 1906, 559, 1907, 559, 1943, 453, 1942], "text": "market"}, {"boundingBox": [567, 1907, 595, 1907, 594, 1943, 566, 1943], "text": "is"}, {"boundingBox": [602, 1907, 737, 1908, 736, 1944, 602, 1943], "text": "expected"}, {"boundingBox": [744, 1908, 775, 1908, 774, 1944, 743, 1944], "text": "to"}, {"boundingBox": [782, 1908, 909, 1909, 909, 1944, 781, 1944], "text": "continue"}, {"boundingBox": [917, 1909, 947, 1909, 946, 1944, 916, 1944], "text": "to"}, {"boundingBox": [954, 1909, 1068, 1909, 1067, 1945, 953, 1944], "text": "change"}, {"boundingBox": [1075, 1909, 1141, 1909, 1140, 1945, 1074, 1945], "text": "over"}, {"boundingBox": [1148, 1909, 1196, 1909, 1194, 1945, 1147, 1945], "text": "the"}, {"boundingBox": [1203, 1909, 1269, 1909, 1268, 1945, 1201, 1945], "text": "next"}, {"boundingBox": [1276, 1909, 1352, 1909, 1350, 1945, 1275, 1945], "text": "year,"}, {"boundingBox": [1359, 1909, 1503, 1909, 1501, 1945, 1357, 1945], "text": "managed"}]}, {"boundingBox": [202, 1946, 1460, 1947, 1459, 1982, 201, 1981], "text": "care reimbursement issues should be confirmed closer to launch. The possibilities of", "words": [{"boundingBox": [206, 1948, 272, 1948, 274, 1979, 208, 1978], "text": "care"}, {"boundingBox": [278, 1948, 506, 1948, 507, 1981, 280, 1979], "text": "reimbursement"}, {"boundingBox": [512, 1948, 612, 1948, 613, 1981, 513, 1981], "text": "issues"}, {"boundingBox": [618, 1948, 718, 1948, 719, 1982, 619, 1981], "text": "should"}, {"boundingBox": [724, 1948, 762, 1947, 763, 1982, 725, 1982], "text": "be"}, {"boundingBox": [770, 1947, 918, 1947, 919, 1982, 771, 1982], "text": "confirmed"}, {"boundingBox": [926, 1947, 1018, 1947, 1019, 1982, 927, 1982], "text": "closer"}, {"boundingBox": [1024, 1947, 1054, 1947, 1055, 1982, 1025, 1982], "text": "to"}, {"boundingBox": [1060, 1947, 1176, 1947, 1177, 1982, 1061, 1982], "text": "launch."}, {"boundingBox": [1182, 1947, 1238, 1947, 1239, 1982, 1183, 1982], "text": "The"}, {"boundingBox": [1244, 1947, 1420, 1947, 1421, 1981, 1245, 1982], "text": "possibilities"}, {"boundingBox": [1426, 1947, 1458, 1947, 1459, 1981, 1427, 1981], "text": "of"}]}, {"boundingBox": [200, 2072, 403, 2073, 402, 2108, 199, 2107], "text": "Confidential", "words": [{"boundingBox": [209, 2073, 402, 2073, 401, 2109, 210, 2108], "text": "Confidential"}]}, {"boundingBox": [804, 2072, 932, 2073, 932, 2108, 803, 2107], "text": "20 of 42", "words": [{"boundingBox": [809, 2074, 848, 2074, 848, 2107, 809, 2107], "text": "20"}, {"boundingBox": [854, 2074, 894, 2073, 893, 2108, 855, 2107], "text": "of"}, {"boundingBox": [902, 2073, 933, 2073, 932, 2109, 902, 2108], "text": "42"}]}, {"boundingBox": [21, 2199, 490, 2204, 489, 2235, 20, 2230], "text": "Confidential Pursuant to Confidentiality", "words": [{"boundingBox": [23, 2200, 166, 2201, 166, 2232, 23, 2230], "text": "Confidential"}, {"boundingBox": [172, 2201, 283, 2202, 284, 2233, 172, 2232], "text": "Pursuant"}, {"boundingBox": [289, 2202, 314, 2203, 315, 2233, 289, 2233], "text": "to"}, {"boundingBox": [320, 2203, 488, 2205, 489, 2236, 321, 2233], "text": "Confidentiality"}]}, {"boundingBox": [27, 2235, 97, 2234, 98, 2260, 27, 2260], "text": "Order", "words": [{"boundingBox": [26, 2233, 96, 2233, 96, 2259, 26, 2259], "text": "Order"}]}, {"boundingBox": [1430, 2207, 1676, 2208, 1675, 2238, 1429, 2236], "text": "KERZC001-000293", "words": [{"boundingBox": [1436, 2208, 1676, 2210, 1675, 2237, 1436, 2237], "text": "KERZC001-000293"}]}, {"boundingBox": [378, 2245, 1331, 2244, 1331, 2281, 379, 2283], "text": "Source: https://www.industrydocuments.ucsf.edu/docs/yrvw0217", "words": [{"boundingBox": [381, 2248, 494, 2248, 494, 2281, 381, 2280], "text": "Source:"}, {"boundingBox": [501, 2248, 1330, 2244, 1330, 2280, 500, 2281], "text": "https://www.industrydocuments.ucsf.edu/docs/yrvw0217"}]}]}]}